Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Reduced GSH form
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): A double-blind, randomised placebo-controlled trial
One such trial found that, on average, Mounjaro reduces BMI by 25.3% by week 88, or roughly 20 months
State that flatly to yourself before you get your hopes up
According to the STEP clinical trials referenced in NICE TA875, patients treated with Wegovy achieved substantial weight loss, typically in the range of 10-15% of initial body weight over 68 weeks of treatment when combined with lifestyle interventions
More independent studies from a public health perspective are needed." The reviews highlight the need for long-term, independent investigations to guide clinical and policy decisions and to better define the role of GLP-1 receptor agonists in lasting weight management
